Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now

You can switch off notifications anytime using browser settings.
Stock Analysis, IPO, Mutual Funds, Bonds & More

IRDAI proposals gives clarity on renewing own damage motor insurance policy

According to the latest draft proposal issued by the insurance regulator on Monday, standalone OD cover may be allowed where long-term liability policy is mandated. The expiry of OD cover should not be later than the expiry of the liability policy.

RIL becomes first Indian company to hit Rs 10 lakh crore market cap

It took a little more than a month for the firm to add another Rs 1 lakh crore to its valuation.

We stay away from companies with questionable management: Rajeev Thakkar of PPFAS Mutual Fund

'We have stayed away from frothy valuations. This has helped in withstanding the severe selloff seen in 2018 in the broader markets.'

Essel Group repays mutual funds after promoter stake sale

The recovery is on loans that were given to Essel, with ZEE shares used as collateral.

Trai floats paper on transparent reporting of tariffs

Trai floats paper on transparent reporting of tariffs

The consultation paper from Trai has been issued when telecom operators have announced their plan to raise tariffs.

Sebi issues guidelines for preferential issue by listed REITs

The regulator said a listed REIT may make a preferential issue of units or an institutional placement of units.

Investing in quality companies paid off, says Jinesh Gopani, head-equities, Axis Mutual Fund

Axis Mutual Fund was the top performer in 2018, and it is topping the performance chart in 2019 also.

Market at record level: what should first-time mutual fund investors do?

When the benchmarks scale new peaks, what must small investors do? That answer lies in their risk appetite, which by itself is a function of familiarity with D-Street.

Simplifying fineprint, big plan of insurance companies

While a few of the startups are simplifying the language of their write-ups, others are working on design elements like graphics, pictures and videos to explain product details to minimise confusion among customers.

Pharma Inc agrees to cap margins on non-price control drugs at 30%

Pharma Inc agrees to cap margins on non-price control drugs at 30%

Big pharma companies with generic divisions — such as Sun Pharma, Cipla and Lupin — will have to reduce MRP.

Page 7 of 15
7 | 8 | 9 | 10 | 11 | 12 | 13 |

Other useful Links

Follow us on

Download et app

Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service